Evidence map›Paper›PMID 27926886›Full record

ArticleDiabetes care2016

The Impact of Precision Medicine in Diabetes: A Multidimensional Perspective.

Stephen S Rich, William T Cefalu

Abstract read
In one paragraph

Article in Diabetes care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Rapid Point-of-Care Test for Determination of C-Peptide Levels.Journal of diabetes science and technology · 2022
    Article
  3. Precision Health Care Elements, Definitions, and Strategies for Patients with Diabetes: A Literature Review.International journal of environmental research and public health · 2021
    Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stephen S RichCenter for Public Health Genomics, University of Virginia, Charlottesville, VA ssr4n@virginia.edu.
William T CefaluPennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA.

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Leigh Lamonica · 2012 to 2026
$69.1M
Type 1 Diabetes Genetics ConsortiumU01DK062418 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RICH, STEPHEN S. · 2002 to 2007
$59.8M
Pregnane and Glycosides and Obesity/llya RaskinP50AT002776 · NCCIH · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI RASKIN, ILYA · 2005 to 2019
$24.9M
Rare Variants and Risk of Type 1 DiabetesR01DK096926 · NIDDK · UNIVERSITY OF VIRGINIA · PI RICH, STEPHEN S. · 2012 to 2015
$2.3M
NCCIH NIH HHS P50 AT002776NIDDK NIH HHS R01 DK096926NIDDK NIH HHS U01 DK062418NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27926886
PMCPMC5079611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.